60 Degrees Pharmaceuticals, Inc. (SXTP)

1.07 -0.01 (-0.93%) USD  |  NASDAQ  |  Aug 25, 14:52
More

60 Degrees Pharmaceuticals Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for SXTP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2024. Start Trial.
Date Value
August 17, 2026 --
May 22, 2026 --
May 20, 2026 --
April 09, 2026 --
March 31, 2026 --
January 27, 2026 --
December 31, 2025 --
November 27, 2025 --
November 14, 2025 --
September 03, 2025 --
June 02, 2025 --
May 16, 2025 --
April 07, 2025 --
Date Value
March 28, 2025 --
December 31, 2024 --
November 23, 2024 --
November 15, 2024 --
August 20, 2024 --
August 15, 2024 --
May 21, 2024 --
May 16, 2024 --
April 08, 2024 --
April 03, 2024 --
February 26, 2024 --
February 02, 2024 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Harrow, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade
Johnson & Johnson Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade